Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:459091.
doi: 10.1155/2014/459091. Epub 2014 May 18.

Intraductal papillary neoplasms of the bile duct

Affiliations
Review

Intraductal papillary neoplasms of the bile duct

Masayuki Ohtsuka et al. Int J Hepatol. 2014.

Abstract

Intraductal papillary neoplasm of the bile duct (IPNB) is a rare variant of bile duct tumors characterized by papillary growth within the bile duct lumen and is regarded as a biliary counterpart of intraductal papillary mucinous neoplasm of the pancreas. IPNBs display a spectrum of premalignant lesion towards invasive cholangiocarcinoma. The most common radiologic findings for IPNB are bile duct dilatation and intraductal masses. The major treatment of IPNB is surgical resection. Ultrasonography, computed tomography, magnetic resonance image, and cholangiography are usually performed to assess tumor location and extension. Cholangioscopy can confirm the histology and assess the extent of the tumor including superficial spreading along the biliary epithelium. However, pathologic diagnosis by preoperative biopsy cannot always reflect the maximum degree of atypia, because IPNBs are often composed of varying degrees of cytoarchitectural atypia. IPNBs are microscopically classified into four epithelial subtypes, such as pancreatobiliary, intestinal, gastric, and oncocytic types. Most cases of IPNB are IPN with high-grade intraepithelial neoplasia or with an associated invasive carcinoma. The histologic types of invasive lesions are either tubular adenocarcinoma or mucinous carcinoma. Although several authors have investigated molecular genetic changes during the development and progression of IPNB, these are still poorly characterized and controversial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative images of intraductal papillary neoplasm of the bile duct on computed tomography. Localized bile duct dilatation and an intraductal mass are shown (arrows).
Figure 2
Figure 2
A representative case of intraductal papillary neoplasm of the bile duct with mucin hypersecretion. (a) Endoscopic retrograde cholangiogram. Diffuse dilatation of the common bile duct with amorphous filling defect is shown. (b) Duodenoscopy shows a dilated papillary orifice with mucin.
Figure 3
Figure 3
Peroral cholangioscopy reveals a papillary tumor within the lumen of the bile duct, but no obvious superficial spreading along the biliary epithelium is observed.
Figure 4
Figure 4
Macroscopic findings of intraductal papillary neoplasm of the bile duct. (a) A polypoid mass (arrow) is elevated into the lumen of the bile duct. (b) Polypoid mural nodules (arrowheads) are observed in the well-defined cystic lesion. This lesion was communicated with the bile duct.
Figure 5
Figure 5
Microscopic findings of intraductal papillary neoplasm of the bile duct. Prominent papillary proliferation with delicate fibrovascular cores is a characteristic feature. Epithelial subtypes are classified as pancreatobiliary (a), intestinal (b), gastric (c), and oncocytic (d).

Similar articles

Cited by

References

    1. Sakamoto E, Nimura Y, Hayakawa N, et al. Clinicopathological studies of mucin-producing cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Surgery. 1997;4(2):157–162.
    1. Chen M, Jan Y, Chen T. Clinical studies of mucin-producing Cholangiocellular carcinoma a study of 22 histopathology-proven cases. Annals of Surgery. 1998;227(1):63–69. - PMC - PubMed
    1. Shibahara H, Tamada S, Goto M, et al. Prognostic features of mucin-producing bile duct tumors. Two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. American Journal of Surgical Pathology. 2004;28(3):327–338. - PubMed
    1. Kuo C, Changchien C, Wu K, et al. Mucin-producing cholangiocarcinoma: clinical experience of 24 cases in 16 years. Scandinavian Journal of Gastroenterology. 2005;40(4):455–459. - PubMed
    1. Kim HJ, Kim MH, Lee SK, et al. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32(5):389–393. - PubMed

LinkOut - more resources